Pharnext renforce son équipe de direction avec la nomination de ScottJohnson au poste de VP, Directeur de la Qualité
Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors
Inotrem Receives Funding from the Crohn’s & Colitis Foundation to helpdevelop new therapeutic approaches in Inflammatory Bowel Disease (IBD)
Brenus Pharma and InSphero receive €1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010
